ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1128

Validation Of a Rapid, Quantitative Method Of Magnetic Resonance Imaging-Detected Osteoarthritis-Related Bone Marrow Lesions In The Patellofemoral Joint

Charles Ratzlaff1 and Jeffrey W. Duryea2, 1Harvard Medical School / Brigham and Women's Hospital, Boston, MA, 2Dept of Radiology, Brigham & Women, Boston, MA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Imaging, Knee and osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Imaging of Rheumatic Diseases II: Imaging in Spondyloarthritis and Osteoarthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose : We recently developed an efficient semi-automated measure of tibial and femoral BML volume and validated it against the Whole-Organ Magnetic Resonance Imaging Score (WORMS). Since patella-femoral (PFJ) osteoarthritis (OA) is increasingly being recognized as a cause of knee pain in OA, we have extended the method to the PFJ. The purpose of this study was to compare PFJ BML volumes with WORMS, and test the hypothesis that PFJ BML volume is associated with stair-climbing pain (but not walking or standing pain).

Methods: 115 subjects from the baseline data of the Osteoarthritis Initiative (OAI) Progression Cohort whose knees were WORMS-scored by OAI central imaging were included. Sagittal turbo spin echo fat saturated (TSE FS) (0.357 x 0.357 x 3.0 mm, TR 3200ms, TE 30ms) IW MRI were obtained on a 3T Siemens Trio MR system. A reader used software to segment subchondral BMLs in the patella and anterior femur (trochlea). The software applies a grayscale thresholding algorithm to the raw image and reader judgment is used to select, usually with 1 or 2 mouse clicks, the clinically appropriate region(s) of BML. Reliability on a random sample of 20 subjects was: ICC 0.96, and 0.97 for intra-and inter-reader respectively.

Primary outcome: segmented volume of BMLs (mm3) in the patella and trochlear femoral compartment.

WORMS score: Comparison of PFJ BML volume was made with OAI public-release WORMS scoring for the patella and trochlea. WORMS reports BML in 4 categories based on size of BML relative to the total sub-region (0-no BML, 1-<25%, 2-25-50%, 3->50%). Spearman’s correlation and Kruskall-Wallis tests were used to assess association between the two methods.

Pain. We used the WOMAC pain sub-scale and defined the primary outcome of knee pain dichotomously as moderate to severe pain (scores 2-4) on any of the 3 weight-bearing (WB) WOMAC pain questions (pain on walking, climbing stairs, standing), acquired at the same baseline OAI visit as the MRI scans. Kruskall-Wallis test were used to assess the associations.

Results: The sample was 84% white, 52% male and were 90% K-L grade 2 and 3. Median BML volumes were progressively larger by WORMS category for patella (figure), trochlea and PFJ (all p<0.001) and strongly correlated (Spearman's r = 0.89, 0.74 and 0.81 respectively, all p=0.000). We found significant positive associations between stair-climbing pain and PFJ BML volume but not for other WOMAC WB pain items.

Conclusion: This study reports good criterion and clinical validation of an efficient method for measuring BML in the PFJ, providing a a potentially useful tool for trials in the PFJ.


Disclosure:

C. Ratzlaff,
None;

J. W. Duryea,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/validation-of-a-rapid-quantitative-method-of-magnetic-resonance-imaging-detected-osteoarthritis-related-bone-marrow-lesions-in-the-patellofemoral-joint/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology